 Hybridoma technology has been replaced by recombinant DNA technology, transgenic mice and phage display.To reduce murine antibody immunogenicity (attacks by the immune system against the antibody), murine molecules were engineered to remove immunogenic content and to increase immunologic efficiency.This was initially achieved by the production of chimeric (suffix "-ximab)" and humanized antibodies (suffix "-zumab").